Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
rEVO Biologics
rEVO Biologics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Atryn
Antithrombin alfa
2009-02-06
Antithrombin iii deficiency
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Antithrombin alfa
cardiopulmonary bypass
,
postoperative hemorrhage
,
pre-eclampsia
,
thrombosis
,
venous thrombosis
,
antithrombin iii deficiency
,
thrombophilia
Benzocaine
antithrombin iii deficiency
,
thrombosis
,
venous thrombosis
Serine
breast neoplasms
,
hematologic neoplasms
,
neoplasms
,
neoplasm metastasis
,
pleural empyema
,
empyema
,
myocardial infarction
,
st elevation myocardial infarction
,
infarction
,
thrombosis
Bevifimod
chronic hepatitis b
,
chronic hepatitis
,
hepatocellular carcinoma
,
liver neoplasms
Nadide
neoplasms
,
breast neoplasms
,
non-hodgkin lymphoma
,
colorectal neoplasms
Crystalloid
healthy volunteers/patients
,
postoperative pain
,
bunion
,
bursitis
,
pain
,
osteoarthritis
,
knee osteoarthritis
,
dental pins
,
toothache
,
hip osteoarthritis
Rfviia
healthy volunteers/patients
,
hemostasis
,
hemorrhagic disorders
,
liver cirrhosis
,
fever
,
dengue
,
severe dengue
,
viral hemorrhagic fevers
,
hematoma
,
cystitis
,
fibrosis
,
spinal fusion
,
hemorrhage
,
cerebral hemorrhage
,
wounds and injuries
,
cardiac surgical procedures
,
congenital heart defects
,
heart diseases
,
hemorrhagic stroke
,
blood coagulation disorders
,
hemostatic disorders
,
hemophilia a
,
hemophilia b
,
postpartum hemorrhage
,
thrombasthenia
,
hemorrhagic shock
,
traumatic brain hemorrhage
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use